Amador Bioscience
The computed 12-month bankruptcy probability of Amador Bioscience is 2.0% (moderate). The 2024 annual accounts show negative equity (€-2.60M) and a net result of €-900k. Equity is shrinking by ~60.8% per year across the filed fiscal years. Its solvency ranks better than 5% of 174 sector peers (fiscal year 2024). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €-2.60M |
| Net result | €-900k |
| Better than sector | 5% |
| Active | 4 yrs |
Mixed profile: strong on profitability, weaker on health.
All 5 axes are computed from data Checked has read.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | -569.1% | 55.0% | |
| Net result | €-900k | €16k | |
| Equity | €-2.60M | €70k | |
| Gross operating margin | €-202k | €41k | |
| Staff costs | €595k | €58k |
| Fiscal year | 2024 |
|---|---|
| Deposit | micro |
| Revenue | - |
| EBITDA | €-880k |
| Net profit | €-900k |
| Cash flow | €-884k |
| Staff costs | €595k |
| Income taxes | €431 |
| Dividends | - |
| Total assets | €456k |
| Equity | €-2.60M |
| Debt | €3.05M |
| of which ≤ 1y | €3.04M |
| of which > 1y | - |
| Working capital | €-2.67M |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 0.12 |
| Quick ratio | 0.12 |
| Working capital ratio | -584.6% |
| Solvency | -569.1% |
| Debt / equity | -1.18 |
| Long-term debt ratio | - |
| Interest coverage | -214.14 |
| Gross margin | - |
| Net margin | - |
| ROA | -197.2% |
| ROE | 34.6% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €456k |
| Fixed assets | 21/28 | €86k |
| Tangible fixed assets | 22/27 | €48k |
| Financial fixed assets | 28 | €38k |
| Current assets | 29/58 | €370k |
| Amounts receivable within one year | 40/41 | €231k |
| Cash & bank | 54/58 | €137k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €456k |
| Equity | 10/15 | €-2.60M |
| Contributions / capital | 10/11 | €100k |
| Accumulated profits (losses) | 14 | €-2.70M |
| Amounts payable | 17/49 | €3.05M |
| Amounts payable within one year | 42/48 | €3.04M |
| Trade debts payable within one year | 44 | €68k |
| Income statement | ||
| Gross operating margin | 9900 | €-202k |
| Operating result | 9901 | €-895k |
| Financial income | 75 | €1 |
| Financial charges | 65 | €4k |
| Result before taxes | 9903 | €-899k |
| Income taxes | 67/77 | €431 |
| Net result for the period | 9904 | €-900k |
| Result to be appropriated | 9905 | €-900k |
-
Current14-11-2025 → present
-
Current14-11-2025 → present
Former directors (3)
-
Former- → 30-06-2026
-
Former01-05-2025 → 30-06-2026
4 events
- 30-06-2026 Resigned· Niet statutaire bestuurder
- 30-06-2026 Resigned· Persoon belast met dagelijks bestuur
- 14-11-2025 Appointed· Director
- 01-05-2025 Appointed· Manager
-
Former17-06-2022 → 01-05-2025
2 events
- 01-05-2025 Resigned· Manager
- 17-06-2022 Appointed· Daily management
| NACE primary | Speur- en ontwikkelingswerk op biotechnologisch gebied(72101) |
| Legal form | Private limited company(610) |
| Incorporation | 11-01-2022 |
| Status | Active |
| Postal code | 3500 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 71322A0540/00G003 | Flanders | 2.9 ha | 1 · 2,491 m² | 2.6 m |
| 71326F0010/00C003 | Flanders | 5,413 m² | 1 · 1,479 m² | 20.9 m · 4 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
30-07-2026 Act object · General meeting · Board meeting · Officer resignation
- Act object: DIVERSEN · Amador Bioscience
- Publication: 30/07/2026 · Amador Bioscience
- Filing: 28-07-2026 · Amador Bioscience
- General meeting: 30/06/2026 · Amador Bioscience
- General meeting: 03/07/2026 · Amador Bioscience
- Board meeting: 03/07/2026 · Amador Bioscience
- Officer resignation: role: niet-statutaire bestuurder, end_date: 2026-06-30 · Otilia Lillin
- Officer resignation: role: persoon belast met dagelijks bestuur, end_date: 2026-06-30 · Otilia Lillin
- Officer resignation: role: persoon belast met dagelijks bestuur, end_date: 2026-06-30 · Chen Xiaomin
- Filing representative · Coenegrachts Godelieve
Technical details
{
"facts": [
{
"type": "act_object",
"quote": "Onderwerp akte : DIVERSEN",
"value": "DIVERSEN",
"object": null,
"subject": "e1"
},
{
"date": "2026-07-30",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 30/07/2026",
"value": "30/07/2026",
"object": null,
"subject": "e1"
},
{
"date": "2026-07-28",
"type": "filing",
"quote": "Neergelegd 28-07-2026",
"value": "28-07-2026",
"object": null,
"subject": "e1"
},
{
"date": "2026-06-30",
"type": "general_meeting",
"quote": "Bij beraadslaging dd. 30/06/2026 heeft de algemene vergadering over de volgende zaken vergaderd",
"value": "30/06/2026",
"object": null,
"subject": "e1"
},
{
"date": "2026-07-03",
"type": "general_meeting",
"quote": "Bij beraadslaging dd. 03/07/2026 heeft de algemene vergadering over de volgende zaken vergaderd",
"value": "03/07/2026",
"object": null,
"subject": "e1"
},
{
"date": "2026-07-03",
"type": "board_meeting",
"quote": "Bij beraadslaging dd. 03/07/2026 heeft het bestuursorgaan over de volgende zaken vergaderd",
"value": "03/07/2026",
"object": null,
"subject": "e1"
},
{
"type": "officer_resignation",
"quote": "De algemene vergadering beslist tot het ontslag van Otilia Lillin ... als niet-statutaire bestuurder, en dit met ingang op 30/06/2026.",
"value": {
"role": "niet-statutaire bestuurder",
"end_date": "2026-06-30"
},
"object": "e1",
"subject": "e2",
"_value_raw": {
"role": "niet-statutaire bestuurder",
"end_date": "30/06/2026"
}
},
{
"type": "officer_resignation",
"quote": "Het bestuursorgaan beslist tot het ontslag van Lillin Otilia als persoon belast met dagelijks bestuur met ingang op 30/06/2026.",
"value": {
"role": "persoon belast met dagelijks bestuur",
"end_date": "2026-06-30"
},
"object": "e1",
"subject": "e2",
"_value_raw": {
"role": "persoon belast met dagelijks bestuur",
"end_date": "30/06/2026"
}
},
{
"type": "officer_resignation",
"quote": "Het bestuursorgaan beslist tot het ontslag van Chen Xiaomin als persoon belast met dagelijks bestuur met ingang op 30/06/2026.",
"value": {
"role": "persoon belast met dagelijks bestuur",
"end_date": "2026-06-30"
},
"object": "e1",
"subject": "e3",
"_value_raw": {
"role": "persoon belast met dagelijks bestuur",
"end_date": "30/06/2026"
}
},
{
"type": "filing_representative",
"quote": "Ingediend door Coenegrachts Godelieve, lasthebber.",
"value": null,
"object": "e1",
"subject": "e5"
}
],
"act_meta": {
"outcome": "clean",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 2634,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "0779.966.013",
"kind": "company",
"name": "Amador Bioscience",
"attrs": {
"seat": "Hasselt, Hendrik van Veldekesingel 150 61, 3500 Belgi\u00EB",
"legal_form": "Besloten Vennootschap"
}
},
{
"id": "e2",
"kbo": null,
"kind": "person",
"name": "Otilia Lillin",
"attrs": {
"address": "69593 Finnerodja Torpaskoga Trindasen"
}
},
{
"id": "e3",
"kbo": null,
"kind": "person",
"name": "Chen Xiaomin",
"attrs": {}
},
{
"id": "e4",
"kbo": null,
"kind": "person",
"name": "Cao Ruiying",
"attrs": {}
},
{
"id": "e5",
"kbo": null,
"kind": "person",
"name": "Coenegrachts Godelieve",
"attrs": {}
}
]
}16-12-2025 3 directors appointed
- Ruiying CAO, Bestuurder
- Otilia LILLIN, Bestuurder
- Yiging HUANG, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Ruiying CAO",
"address": null,
"birth_date": null
},
"effective_date": "2025-11-14",
"evidence_quote": "beslist om het aantal bestuurders te bepalen op vier (4) en om te benoemen als bijkomend bestuurder van de Vennootschap, met ingang van 14 november 2025, voor onbepaalde duur: mevrouw Ruiying CAO, wonende te Room 2011, Jiangning Road No. 599, Shanghai (China);"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Otilia LILLIN",
"address": null,
"birth_date": null
},
"effective_date": "2025-11-14",
"evidence_quote": "beslist om het aantal bestuurders te bepalen op vier (4) en om te benoemen als bijkomend bestuurder van de Vennootschap, met ingang van 14 november 2025, voor onbepaalde duur: mevrouw Otilia LILLIN, wonende te Torpaskoga Trindasen, 695 93 Finner\u00F6dja (Zweden);"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Yiging HUANG",
"address": null,
"birth_date": null
},
"effective_date": "2025-11-14",
"evidence_quote": "beslist om het aantal bestuurders te bepalen op vier (4) en om te benoemen als bijkomend bestuurder van de Vennootschap, met ingang van 14 november 2025, voor onbepaalde duur: mevrouw Yiging HUANG, wonende te Room 703, Floor 7, Mofang City, Ningwei Street District Hangzhou, 311200 (China)."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0779.966.013",
"name_full": "AMADOR BIOSCIENCE",
"legal_form": "BV"
}
}24-10-2025 1 director appointed, 1 resigning
- Otilia Lillin, Zaakvoerder
- Nina Bos, Zaakvoerder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Nina Bos",
"address": null,
"birth_date": null
},
"effective_date": "2025-05-01",
"evidence_quote": "Het bestuursorgaan beslist tot het ontslag van Nina Bos, met woonplaats te 3700 Tongeren-Borgloon Astridlaan 94, als persoon belast met dagelijks bestuur met ingang op 01/05/2025."
},
{
"kind": "director_in",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Otilia Lillin",
"address": null,
"birth_date": null
},
"effective_date": "2025-05-01",
"evidence_quote": "Het bestuursorgaan beslist tot de benoeming van Otilia Lillin, met woonplaats te 69593 Finnerodja Torpaskoga Trindasen /, als persoon belast met dagelijks bestuur met ingang op 01/05/2025."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0779.966.013",
"name_full": "AMADOR BIOSCIENCE",
"legal_form": "BV"
}
}22-01-2025 Registered office moved within Hasselt
- Kempische Steenweg 309, 3500 Hasselt → Hendrik van Veldekesingel 150, 3500 Hasselt
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Hasselt",
"region": null,
"street": "Hendrik van Veldekesingel",
"country": "BE",
"postcode": "3500",
"box_number": "61",
"street_number": "150"
},
"old_address": {
"city": "Hasselt",
"region": null,
"street": "Kempische Steenweg",
"country": "BE",
"postcode": "3500",
"box_number": "1.03",
"street_number": "309"
},
"effective_date": "2025-01-14",
"evidence_quote": "Uit het verslag van de Bijzondere Algemene Vergadering, gehouden dd 14 dcember ten maatschappelijke zetel werd met eenparigheid van stemmen beslist om vanaf heden de maatschappelijke zetel te verplaatsen naar Hendrik van Veldekesingel 150 box 61 te 3500 Hasselt."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0779.966.013",
"name_full": "AMADOR BIOSCIENCE",
"legal_form": "BV"
}
}08-07-2022 Nina BOS appointed as daily management
- Nina BOS, Dagelijks bestuur
Technical details
{
"events": [
{
"kind": "director_in",
"role": "dagelijks_bestuur",
"person": {
"rrn": null,
"name": "Nina BOS",
"address": null,
"birth_date": null
},
"effective_date": "2022-06-17",
"evidence_quote": "beslist om - in toepassing van artikel 20 van de Statuten - te benoemen als dagelijks bestuurder, in het kader van de uitoefening van het dagelijks bestuur, met ingang van 17 juni 2022, voor onbepaalde duur: mevrouw Nina BOS, wonende te 3700 Tongeren, Astridlaan 94."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0779.966.013",
"name_full": "AMADOR BIOSCIENCE",
"legal_form": "BV"
}
}13-01-2022 Incorporation of a new BV
Technical details
{
"kind": "oprichting",
"seat": "3500 Hasselt, Kempische Steenweg 309 bus 1.03",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1971-09-22",
"name": "BING Wang",
"niss": null,
"address": "5215 Pembroke Way, San Ramon, CA 94582, United States"
},
"share_class": "Ordinary",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 0.0,
"holder_person_name": "BING Wang",
"is_subscriber_only": true,
"n_shares_subscribed": 1000,
"amount_subscribed_eur": 100000.0,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 100000.0,
"subject_company": {
"kbo": "0779.966.013",
"name_full": "Amador Bioscience",
"legal_form": "BV"
},
"initial_directors": [],
"incorporation_date": "2022-01-07",
"post_incorporation_mandates": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | Amador Bioscience |